计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| N413595-2mg |
2mg |
现货 ![]() |
| |
| N413595-5mg |
5mg |
现货 ![]() |
| |
| N413595-10mg |
10mg |
现货 ![]() |
| |
| N413595-25mg |
25mg |
现货 ![]() |
| |
| N413595-50mg |
50mg |
现货 ![]() |
| |
| N413595-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | MLS000756413-02 | D70755 | MLS000104342 | NSC185058 | NSC-185058 | BS-16731 | SMR000054277 | N-(2-pyridyl)thiopicolinamide | N-(pyridin-2-yl)pyridine-2-carbothioamide | 2-Pyridinecarbothioamide, N-2-pyridinyl- | MFCD00448857 | N-pyridin-2-ylpyridine-2-car |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | NSC 185058 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
NSC 185058 是一种 ATG4B 抑制剂。ATG4B 是一种主要的半胱氨酸蛋白酶 (cysteine protease)。NSC185058 抑制 ATG4B 从而显著减弱自噬 (autophagic) 活性
体内活性 Information NSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways. NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible modification of ATG8. Inclusion of the ATG4B inhibitor NSC185058 enhances the anti-tumor activity of radiation therapy (RT). NSC185058 decreases glioblastoma (GBM) cell tumorigenicity, and enhances the anti-tumor activity of RT when applied to orthotopic GBM xenograft models |
| 纯度 | ≥98% |
| ALogP | 2.652 |
|---|---|
| hba_count | 2 |
| HBD Count | 1 |
| Rotatable Bond | 3 |
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504760099 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | N-pyridin-2-ylpyridine-2-carbothioamide |
| INCHI | 1S/C11H9N3S/c15-11(9-5-1-3-7-12-9)14-10-6-2-4-8-13-10/h1-8H,(H,13,14,15) |
| InChi Key | UGWOJXZJIZUKDP-UHFFFAOYSA-N |
| Smiles | C1=CC=NC(=C1)C(=S)NC2=CC=CC=N2 |
| Isomeric SMILES | C1=CC=NC(=C1)C(=S)NC2=CC=CC=N2 |
| 分子量 | 215.27 |
| Reaxy-Rn | 151073 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=151073&ln= |
| 溶解性 | DMSO: 43 mg/mL (199.75 mM) Ethanol:21 mg/mL (97.55 mM) |
|---|---|
| 敏感性 | 对光敏感 |
| DMSO(mg / mL) Max Solubility | 43 |
| DMSO(mM) Max Solubility | 199.749152227435 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 215.280 g/mol |
| XLogP3 | 1.900 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 215.052 Da |
| 单同位素质量Monoisotopic Mass | 215.052 Da |
| 拓扑极表面积Topological Polar Surface Area | 69.900 Ų |
| 重原子数Heavy Atom Count | 15 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 220.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 |